|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Anika Therapeutics Inc., of Woburn, Mass., renewed its contract with Boehringer Ingelheim Vetmedica Inc., a subsidiary of Boehringer Ingelheim Corp., of Ridgefield, Conn., to market Anika's Hyvisc product. Hyvisc is an injectable, high-molecular-weight hyaluronic acid-based product used in the treatment of joint dysfunction in horses with equine osteoarthritis. The contract extends exclusive U.S. marketing rights to Boehringer through May 2006.
Ariad Pharmaceuticals Inc., of Cambridge, Mass., said that Ariad, the Massachusetts Institute of Technology, the Whitehead Institute for Biomedical Research and the president and fellows of Harvard College filed a patent ...